The effect of a somatostatin analogue (SMS 201-995, sandostatin) on the concentration of phosphoribosyl pyrophosphate and the activity of the pentose phosphate pathway in the early renal hypertrophy of experimental diabetes in the rat
- 1 April 1988
- journal article
- research article
- Published by Elsevier in Biochemical Medicine and Metabolic Biology
- Vol. 39 (2) , 226-233
- https://doi.org/10.1016/0885-4505(88)90080-1
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Concentration of phosphoribosyl pyrophosphate in the kidney during development and in experimental diabetic hypertrophyBiochemical Journal, 1986
- Renal hypertrophy in experimental diabetes. Changes in pentose phosphate pathway activityDiabetes, 1985
- Renal hypertrophy in experimental diabetes mellitusKidney International, 1983
- Insulin-Like Growth Factors: A Role in Growth Hormone Negative Feedback and Body Weight Regulation via BrainScience, 1983
- Regulation of pathways of glucose metabolism in kidneyFEBS Letters, 1982
- Acute renal hypertrophy in experimental diabetes: Lack of effect of short-term growth hormone administrationDiabetologia, 1981
- Alterations in glomerular RNA in diabetic rats: Roles of glucagon and insulinKidney International, 1981
- Growth hormone enhances basement membrane thickening in experimental diabetesDiabetologia, 1978
- Renal hypertrophy in experimental diabetes: Relation to severity of diabetesDiabetologia, 1977
- Growth Hormone Secretion and Kidney Function During Normalization of the Metabolic State in Newly Diagnosed Juvenile DiabetesHormone and Metabolic Research, 1972